Show simple item record

dc.contributor.authorNeil, Men_US
dc.contributor.authorFenton, Nen_US
dc.contributor.authorOsman, Men_US
dc.contributor.authorMcLachlan, Sen_US
dc.date.accessioned2020-09-10T11:01:46Z
dc.date.available2020-05-13en_US
dc.date.issued2020-05-26en_US
dc.identifier.issn1366-9877en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/66948
dc.description.abstractWidely reported statistics on Covid-19 across the globe fail to take account of both the uncertainty of the data and possible explanations for this uncertainty. In this paper we use a Bayesian Network (BN) model to estimate the Covid-19 infection prevalence rate (IPR) and infection fatality rate (IFR) for different countries and regions, where relevant data are available. This combines multiple sources of data in a single model. The results show that Chelsea Mass. USA and Gangelt Germany have relatively higher infection prevalence rates (IPR) than Santa Clara USA, Kobe, Japan and England and Wales. In all cases the infection prevalence is significantly higher than what has been widely reported, with much higher community infection rates in all locations. For Santa Clara and Chelsea, both in the USA, the most likely IFR values are 0.3-0.4%. Kobe, Japan is very unusual in comparison with the others with values an order of magnitude less than the others at, 0.001%. The IFR for Spain is centred around 1%. England and Wales lie between Spain and the USA/German values with an IFR around 0.8%. There remains some uncertainty around these estimates but an IFR greater than 1% looks remote for all regions/countries. We use a Bayesian technique called "virtual evidence" to test the sensitivity of the IFR to two significant sources of uncertainty: survey quality and uncertainty about Covid-19 death counts. In response the adjusted estimates for IFR are most likely to be in the range 0.3%-0.5%.en_US
dc.publisherTaylor & Francis (Routledge)en_US
dc.relation.ispartofJournal of Risk Researchen_US
dc.titleBayesian Network Analysis of Covid-19 data reveals higher Infection Prevalence Rates and lower Fatality Rates than widely reporteden_US
dc.typeArticle
dc.rights.holderThis is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Risk Research following peer review. The version of record is available https://www.tandfonline.com/doi/full/10.1080/13669877.2020.1778771
dc.identifier.doi10.1101/2020.05.25.20112466en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
dcterms.dateAccepted2020-05-13en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record